Zevra Therapeutics, Inc.ZVRANASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+118.8%
5Y CAGR+51.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+118.8%/yr
Annual compound
5Y CAGR
+51.6%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$106.47M+350.9%
2024$23.61M-14.0%
2023$27.46M+170.3%
2022$10.16M-64.5%
2021$28.65M+115.6%
2020$13.29M+3.5%
2019$12.84M-
2018$0.00-
2017$0.00-
2016$0.00-